Cargando…

The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer

AKR1C3 is a novel therapeutic target in castration-resistant prostate cancer (CRPC) and estrogen receptor (ER)-positive breast cancer because of its ability to produce testosterone and 17β-estradiol intratumorally, thus promoting nuclear receptor signaling and tumor progression. A panel of CRPC, ER-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yarong Diana, Fu, Melissa, Brooke, Darby G., Heinrich, Daniel M., Denny, William A., Jamieson, Stephen M. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061482/ https://www.ncbi.nlm.nih.gov/pubmed/24995161 http://dx.doi.org/10.3389/fonc.2014.00159

Ejemplares similares

AKR1C3 Inhibition Therapy in Castration-Resistant Prostate Cancer and Breast Cancer: Lessons from Responses to SN33638
por: Zhou, Wen, et al.
Publicado: (2014)

AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol
por: Detlefsen, Andrea J., et al.
Publicado: (2023)

From mitochondria to sarcopenia: role of 17β-estradiol and testosterone
por: Tian, Xu, et al.
Publicado: (2023)

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2018)

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer
por: Stein, Mark, et al.
Publicado: (2012)

Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3
por: Yu, Xiaoping, et al.
Publicado: (2023)

Peripubertal Testosterone, 17β-Estradiol and Progesterone Concentrations in Hair and Nails in Dobermann Dogs
por: Fusi, Jasmine, et al.
Publicado: (2023)

Challenges and improvements in testosterone and estradiol testing
por: Vesper, Hubert W, et al.
Publicado: (2014)

The Treatment of Vestibulodynia with Topical Estradiol and Testosterone
por: Burrows, Lara J, et al.
Publicado: (2013)

Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
por: Lam, Hung-Ming, et al.
Publicado: (2018)

An Approach for Investigating Sexual Maturity in Wild Boar Males: Testosterone and 17β-Estradiol Analysis
por: Maistrelli, Claudia, et al.
Publicado: (2022)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression
por: Wang, Xuming, et al.
Publicado: (2017)

Testosterone and estradiol affect adolescent reinforcement learning
por: Kohne, Sina, et al.
Publicado: (2022)

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer
por: Bremmer, Felix, et al.
Publicado: (2018)

Discordance between testosterone measurement methods in castrated prostate cancer patients
por: Rouleau, Mélanie, et al.
Publicado: (2019)

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro
por: Cui, Xiaoli, et al.
Publicado: (2022)

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
por: Liedtke, Andy J., et al.
Publicado: (2013)

17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
por: Vydra, Natalia, et al.
Publicado: (2019)

Evaluation of seasonal changes of serum and plasma estradiol-17β, progesterone and testosterone in dolphins (Tursiops truncatus) by chemiluminescence
por: Fragalà, Santo, et al.
Publicado: (2015)

Coat, Claw and Dewclaw 17-β-Estradiol and Testosterone Concentrations in Male and Female Postpubertal Cats: Preliminary Results
por: Fusi, Jasmine, et al.
Publicado: (2023)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation
por: Totta, Pierangela, et al.
Publicado: (2016)

Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
por: Mondal, Samim Ali, et al.
Publicado: (2023)

Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
por: Mondal, Samim Ali, et al.
Publicado: (2023)

17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids
por: Pacheco-Velázquez, Silvia Cecilia, et al.
Publicado: (2022)

17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer
por: Drula, Rares, et al.
Publicado: (2023)

1,25-Dihydroxyvitamin D3 increases testosterone-induced 17beta-estradiol secretion and reverses testosterone-reduced connexin 43 in rat granulosa cells
por: Lee, Ching-Tien, et al.
Publicado: (2014)

The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches
por: Jefferi, Nur Erysha Sabrina, et al.
Publicado: (2023)

Higher testosterone and testosterone/estradiol ratio in men are associated with better epigenetic estimators of mortality risk
por: Kusters, Cynthia DJ, et al.
Publicado: (2023)

Common and unique testosterone and 17 beta-estradiol degradation mechanisms in Comamonas testosteroni JLU460ET by transcriptome analysis
por: Wang, Ze, et al.
Publicado: (2023)

Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
por: Ozyigit, Gokhan, et al.
Publicado: (2019)

Data to support a simultaneous testosterone and estradiol assay in serum by LC-MS/MS
por: Schofield, Ryan C., et al.
Publicado: (2018)

Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk
por: Dorgan, Joanne F, et al.
Publicado: (2010)

Within-person coupling of estradiol, testosterone, and cortisol in women athletes
por: Edwards, David A., et al.
Publicado: (2020)

Evaluation of chemical castration with calcium chloride versus surgical castration in donkeys: testosterone as an endpoint marker
por: Ibrahim, Ahmed, et al.
Publicado: (2016)

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Zhu, Sha, et al.
Publicado: (2022)

In vitro inhibition of porcine cytochrome P450 by 17β -estradiol and 17α-estradiol
por: Zamaratskaia, Galia, et al.
Publicado: (2011)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
por: Caramella, Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s5vneiiduhauvbp53r87he5pt1